About Neurogastrx, Inc.

website icon
Website
employees icon
Employees
industry icon
Industry
Pharmaceuticals
location icon
Location
600 Unicorn Park Dr, Woburn, Massachusetts 01801, US
description icon
Information
We are a privately held, late clinical-stage biopharmaceutical company that is focused on identifying and developing therapies for patients suffering from serious gastrointestinal (GI) diseases. We believe that the lack of innovation and limited treatment options for GI patients present us with a significant opportunity to address this large unmet medical need. Initially, we are focused on pursuing indications for the treatment of patients suffering from erosive esophagitis (EE) and gastroparesis. We believe our approach, which is targeted to the gastroenterology community, combined with the experience of our management team in developing and commercializing medicines in the GI space, positions us to identify, develop and efficiently bring to market solutions for GI diseases with limited innovation and/or treatment options.

Neurogastrx, Inc. Alternatives

Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals

Frequently Asked Questions about Neurogastrx, Inc.

Who is the CEO of Neurogastrx, Inc.?

James O'mara is the CEO of Neurogastrx, Inc.. To contact James O'mara email at [email protected].

Who are the decision makers in Neurogastrx, Inc.?

The decision makers in Neurogastrx, Inc. are Cyril De Colle, James O'mara, Pankaj Jay Pasricha, etc. Click to Find Neurogastrx, Inc. decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more